Global Hemophilia B market expected to reach over US $2 billion by 2019, says Technavio
This industry research report segments the global hemophilia B market by disease severity (mild, moderate, and severe), by disease management (on-demand therapy, prophylaxis, and inhibitors), and by geography (APAC, EMEA, and the Americas). This report also includes a section on the key trends, drivers, and leading vendors in this market, including Baxter, Grifols, Novo…
